about
Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular ActivityTargeting CREB for cancer therapy: friend or foeClustered patterns of species origins of nature-derived drugs and clues for future bioprospecting.Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.Measuring and interpreting the selectivity of protein kinase inhibitorsClustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.
P2860
Q27684390-D5DA8F76-E733-456F-BE85-9445E273D396Q34387213-69F62FFD-8ACB-4CCF-92CE-05E27E909FF3Q35149474-A55126A3-6C70-4DC0-84D9-9C6F8115A562Q35631111-F49B2B45-5205-4C8D-B4A8-103C6FC74AD4Q37032524-063F4ED0-7B03-4893-8140-04E04760A192Q37537075-453F7D37-672F-49C0-887A-02F439295004Q37737158-48441210-1D5D-45F4-B45F-D1AF6F1E3CE6
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Killing two kinase families with one stone.
@en
Killing two kinase families with one stone.
@nl
type
label
Killing two kinase families with one stone.
@en
Killing two kinase families with one stone.
@nl
prefLabel
Killing two kinase families with one stone.
@en
Killing two kinase families with one stone.
@nl
P356
P1476
Killing two kinase families with one stone
@en
P2093
Bart Vanhaesebroeck
Neil Torbett
P2888
P304
P356
10.1038/NCHEMBIO1108-648
P577
2008-11-01T00:00:00Z